Boston, Massachusetts-based Cogito was founded on “the idea of being able to automatically detect distress and depression based on how people are speaking,” Dr. Skyler Place, the company’s chief ...

Cogito, a real-time feedback platform for customer service agents, added $15 million to its coffers today in the form of a Series B. This brings the company’s total fundraising to $22.5 million. The ...

Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline. Cognito, based in Cambridge, Mass., is developing a headset that ...

As it plows ahead in its efforts to secure an FDA greenlight for its light- and sound-based neuromodulation device to treat Alzheimer’s disease, Cognito Therapeutics is taking an even closer look at ...

We’ve all had crappy customer service calls. Primed by staticky elevator music and the ever-mysterious agitating echo, most of us come into calls with strained patience. On the line, customer service ...

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...

A new production company is on the mission to bring weird science to life through story. Neuroscientist and Stanford professor Dr. David Eagleman has teamed up with producers Matt Tauber and Adam ...

Alzheimer's disease is a complicated and debilitating disease that has no cure. One startup is testing whether a "disco" of light and sound can slow the disease in patients. Cognito Therapeutics ...